Michael Arenberg
Operationeel Directeur bij IMAGO BIOSCIENCES, INC.
Actieve functies van Michael Arenberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMAGO BIOSCIENCES, INC. | Operationeel Directeur | 23-03-2022 | - |
Loopbaan van Michael Arenberg
Eerdere bekende functies van Michael Arenberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DURECT CORPORATION | Financieel Directeur/CFO | 15-10-2018 | 17-03-2022 |
Investor Relations Contact | 01-01-1999 | 17-03-2022 | |
Corporate Officer/Principal | 17-07-2009 | 15-10-2018 | |
Bedrijfssecretaris | - | 17-03-2022 | |
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Oprichter | 01-01-1996 | 01-01-1999 |
Verkoop & Marketing | 01-01-1996 | 01-01-1999 |
Opleiding van Michael Arenberg
University of Denver | Graduate Degree |
Leavey School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Director of Finance/CFO | 1 |
Investor Relations Contact | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DURECT CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Health Technology |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Beurs
- Insiders
- Michael Arenberg
- Ervaring